Clin2
NCT06874803Possibly a fitRecruiting

Acupuncture and moxibustion for early Parkinson's motor symptoms

Parkinson's Disease (PD)

Part of Bones, joints & muscles, Brain & nervous system clinical trials.

This trial tests whether acupuncture and moxibustion can help improve movement symptoms in people with early to moderate Parkinson's disease. It is designed to see if adding these treatments to your regular care offers extra benefits.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
30 years to 80 years
Study type
Interventional

Who can take part

  • You must be between 30 and 80 years old.
  • You must have been diagnosed with Parkinson's disease at an early to moderate stage (Hoehn-Yahr stage less than 3).
  • You cannot have had deep brain stimulation (DBS) surgery.
  • You should not have any severe medical conditions like heart, lung, liver, kidney, or blood clotting problems.
  • You must not have received acupuncture or moxibustion in the past 3 months.
  • You cannot be pregnant or breastfeeding, or have a history of allergic reaction to acupuncture or moxibustion.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07625540Recruiting
Targeted Brain Stimulation for Parkinson's Motor and Non-Motor Symptoms

This trial tests a non-invasive brain stimulation technique (using electrical currents applied through the scalp) aimed at the subthalamic nucleus—a brain region involved in movement control—to help reduce both movement-related symptoms (like tremor and stiffness) and non-movement symptoms (like mood and sleep problems) in people with Parkinson's disease.

Shanghai, Shanghai Municipality
NCT07725562Recruiting· Phase 2/Phase 3
VG081821AC tablets for early to mid-stage Parkinson's disease

This trial tests a new oral medication, VG081821AC, in people with early to mid-stage Parkinson's disease. The goal is to see if it can improve movement symptoms and slow the progression of the condition, and it may offer a new treatment option for those not yet on levodopa.

Beijing
NCT07513441Recruiting· Phase 1
Testing Lu AF28996 for Parkinson's disease motor fluctuations

This early-stage trial tests a new medication called Lu AF28996 in Chinese patients with Parkinson's disease who experience predictable on-off episodes (times when medication works well versus poorly). The study aims to see if this drug can help reduce those difficult off periods.

Beijing, Beijing Municipality
NCT06304285Recruiting
Acupuncture for Parkinson's with chronic appendicitis

This trial tests whether acupuncture can help people with Parkinson's disease who also have chronic appendicitis. It aims to see if treating the appendix inflammation may also improve Parkinson's symptoms.

Hefei, Anhui
NCT06390761Recruiting
Acupuncture for constipation in Parkinson's disease

This trial tests whether acupuncture can help relieve constipation in people with Parkinson's disease. If you have both Parkinson's and constipation that is not caused by another medical condition, this study may offer a non-drug treatment option.

Xi'an, Shaanxi
NCT07827456Not yet recruiting
MRI-guided brain stimulation for Parkinson's disease

This trial tests a new non-invasive brain stimulation method guided by MRI to see if it can improve Parkinson's symptoms. It may be an option for people who respond well to their current Parkinson's medications.

Hear when a new Parkinson's Disease (PD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.